Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)NCT06966479UPBPhase 2Active not recruiting2027-09Estimated
Safety and Efficacy of VDPHL01 in Males With AGANCT06972264MANEPhase 3Active not recruiting2026-12Estimated
Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)NCT06973629Brainstorm-Cell TherapeuticsPhase 3Not yet recruiting2028-11-01Estimated
A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDNCT06979544LPCNPhase 3Completed2026-01-16Actual
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078UPBPhase 2Active not recruiting2027-10Estimated
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNCT06982521RLAYPhase 3Recruiting2028-04-30Estimated
Atacicept in Multiple Glomerular DiseasesNCT06983028VERAPhase 2Recruiting2027-11Estimated
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)NCT06985147IRONPhase 2Active not recruiting2027-07Estimated
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or OverweightNCT06987513ALTPhase 2Completed2026-07-30Actual
Phase 2 Study of ADX-038 in Complement-Mediated Kidney DiseaseNCT06989359ADRXPhase 2Recruiting2030-04-30Estimated
Phase 2 Study of ADX-038 in Participants With Geographic AtrophyNCT06990269ADRXPhase 2Recruiting2030-02-28Estimated
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKNCT06990399KODPhase 3Recruiting2027-04Estimated
A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)NCT06990984Thiogenesis Therapeutics, Inc.Phase 2Not yet recruiting2027-06Estimated
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.NCT06991114ARTVPhase 2Recruiting2028-01Estimated
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefenseNCT06993610Zura Bio IncPhase 2Active not recruiting2026-09-18Actual
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerNCT06995677TYRAPhase 2Recruiting2028-02Estimated
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLENCT06996080KODPhase 3Recruiting2027-02Estimated
Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic DermatitisNCT06998056ARQTPhase 2Completed2025-12-04Actual
Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)NCT06999902Praxis Precision MedicinesPhase 2, Phase 3Completed2026-05-14Actual
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyNCT07001800KARDPhase 2, Phase 3Recruiting2028-08-31Estimated
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLNCT07007312KURAPhase 3Recruiting2031-11Estimated
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerNCT07007559ALX Oncology Inc.Phase 2Recruiting2027-12Estimated
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis SuppurativaNCT07007637MoonLake Immunotherapeutics AGPhase 3Enrolling by invitation2028-06-13Estimated
RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)NCT07009860ALTPhase 2Active not recruiting2027-09-30Estimated
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387NCT07010159KNSAPhase 2, Phase 3Recruiting2027-12-31Estimated
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineNCT07010471Praxis Precision MedicinesPhase 3Active not recruiting2026-12Estimated
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisNCT07011706ACRSPhase 2Active not recruiting2026-09-21Actual
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaNCT07011719RCUSPhase 3Recruiting2028-04Estimated
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisNCT07012395SYREPhase 2Recruiting2027-06Estimated
Neoadjuvant Darovasertib in Primary Uveal MelanomaNCT07015190IDEAYA BiosciencesPhase 3Recruiting2030-10Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.